Skip to main content
. 2021 Feb 25;21(5):414. doi: 10.3892/etm.2021.9858

Figure 1.

Figure 1

In silico analysis of ESR1 and AR expression, and the association with patient survival in CC. Genomics of cross-cancer alteration summary of (A) ESR1 and (B) AR genes in tumor and healthy tissues. (C) DFS of the high-ESR1 (HR, 0.73; 95% CI, 0.61-0.90) and low-ESR1 (95% CI, 0.62-0.82) groups. (D) DFS of the high-AR (HR, 0.78; 95% CI, 0.72 to 0.88) and low-AR (95% CI, 0.63-0.83) groups. ESR1, estrogen receptor α gene; AR, androgen receptor; DFS, disease-free survival; CI, confidence interval; HR, hazard ratio.